From Nasdaq: 2025-06-13 19:35:00

Mallinckrodt plc and Endo, Inc. have received shareholder approvals for their merger, a stock-and-cash deal to create a global pharmaceutical leader. The companies will now seek court approval in Ireland, with a sanction hearing expected in July. The merger is set to be finalized soon after the hearing, with the new entity based in Dublin. On Friday, NDOI closed at $20.9 on the OTC Markets OTCQX, a 1.65% decrease from the previous day.



Read more at Nasdaq: Mallinckrodt And Endo Shareholders Approve Merger